These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23439433)

  • 41. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.
    Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA
    Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
    Kogan EA; Tyong FV; Demura SA
    Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis.
    Lu J; Auduong L; White ES; Yue X
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):106-14. PubMed ID: 23962103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
    Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
    Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
    Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.
    Kulasekaran P; Scavone CA; Rogers DS; Arenberg DA; Thannickal VJ; Horowitz JC
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):484-93. PubMed ID: 19188658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Periostin plays a critical role in the cell cycle in lung fibroblasts.
    Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
    Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
    Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
    PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix.
    Nho RS; Hergert P; Kahm J; Jessurun J; Henke C
    Am J Pathol; 2011 Nov; 179(5):2420-30. PubMed ID: 21893017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self DNA perpetuates IPF lung fibroblast senescence in a cGAS-dependent manner.
    Schuliga M; Read J; Blokland KEC; Waters DW; Burgess J; Prêle C; Mutsaers SE; Jaffar J; Westall G; Reid A; James A; Grainge C; Knight DA
    Clin Sci (Lond); 2020 Apr; 134(7):889-905. PubMed ID: 32219338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis.
    Matsuyama W; Watanabe M; Shirahama Y; Mitsuyama H; Higashimoto I; Osame M; Arimura K
    Am J Pathol; 2006 Mar; 168(3):866-77. PubMed ID: 16507902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
    Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
    Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
    [No Abstract]   [Full Text] [Related]  

  • 57. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior.
    Munguía-Reyes A; Balderas-Martínez YI; Becerril C; Checa M; Ramírez R; Ortiz B; Meléndez-Zajgla J; Pardo A; Selman M
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):65-76. PubMed ID: 29345973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway.
    Li X; Ma X; Miao Y; Zhang J; Xi B; Li W; Zhang Q; Chen L; Yang Y; Li H; Wei L; Zhou H; Yang C
    J Cell Mol Med; 2023 Feb; 27(3):422-434. PubMed ID: 36651446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.